Baseline characteristics of colonoscopies performed by GI trainees
| 2019 | 2020 | 2021 | |
| Total colonoscopies | 798 | 172 | 538 |
| Colonoscopies by GI trainees (%) | 367 (46.0) | 44 (25.6) | 243 (45.2) |
| GI trainee-assisted colonoscopies (% of GI trainee colonoscopies) | 46 (12.5) | 5 (11.4) | 45 (18.5) |
| Patient demographics | |||
| Male | 175 (47.7%) | 21 (47.7%) | 127 (52.3%) |
| Female | 192 (52.3%) | 23 (52.3%) | 116 (47.7%) |
| Age, years (median, range) | 59, 18–89 | 62, 25–84 | 57, 16–88 |
| Inpatient | 16 (4.4%) | 22 (50.0%) | 25 (10.3%) |
| Outpatient | 351 (95.6%) | 22 (50.0%) | 218 (89.7%) |
| Indications | |||
| Anaemia | 65 (17.7%) | 19 (43.2%) | 44 (18.1%) |
| Rectal bleeding | 38 (10.4%) | 7 (15.9%) | 54 (22.2%) |
| Diarrhoea* | 66 (18.0%) | 8 (18.2%) | 61 (25.1%) |
| Constipation | 17 (4.6%) | 0 | 21 (8.6%) |
| Abdominal pain | 22 (6.0%) | 3 (6.8%) | 21 (8.6%) |
| Weight loss | 9 (2.5%) | 1 (2.3%) | 1 (0.4%) |
| Polyp/cancer surveillance | 77 (21.0%) | 2 (4.5%) | 18 (7.4%) |
| Family history of polyps/cancer | 63 (17.2%) | 3 (6.8%) | 17 (7.0%) |
| IBD assessment | 33 (9.0%) | 2 (4.5%) | 8 (3.3%) |
| IBD surveillance | 5 (1.4%) | 0 | 12 (4.9%) |
| Abnormality on imaging | 19 (5.2%) | 5 (11.4%) | 27 (11.1%) |
| Other | 11 (3.0%) | 1 (2.3%) | 5 (2.1%) |
*Diarrhoea including alternating bowel habits, urgency and faecal incontinence.
GI, gastrointestinal; IBD, inflammatory bowel disease.